Healthcare Industry News: Animas
News Release - February 17, 2006
Johnson & Johnson Completes Acquisition of Animas CorporationNEW BRUNSWICK, N.J., Feb. 17 (HSMN NewsFeed) -- Johnson & Johnson (NYSE: JNJ ) today announced the completion of its previously announced acquisition of Animas Corporation, an insulin delivery company.
Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 115,600 men and women in 57 countries and sell products throughout the world.
Source: Johnson & Johnson
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsJohnson & Johnson Appoints Senior Leaders to Executive Committee
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021